Lymphocytes transformed by Epstein-Barr virus. Induction of nuclear antigen reactive with antibody in rheumatoid arthritis by unknown
LYMPHOCYTES  TRANSFORMED  BY  EPSTEIN-BARR  VIRUS 
Induction of  Nuclear Antigen 
Reactive with Antibody in Rheumatoid  Arthritis* 
B~ MARGARET  A. ALSPAUGH,~  FRED  C. JENSEN,  HARVEY  RABIN,§ AND ENG  M. 
TAN  H 
(From the Departments of Clinical Research and Immunopathology, Scripps Clinic and Research 
Foundation, La Jolla, California  92037) 
Rheumatoid arthritis  (RA)  I  is a disease  in which immune mechanisms have 
been considered to play a significant  if  not the major role  in  pathogenesis (1-3). 
There have been many studies which support this hypothesis. The synovial 
tissue  of  the peripheral  joints  is  the most important site  of  tissue  injury,  and the 
inflammatory cell  infiltrate  is  composed mostly of  lymphocytes and plasma cells 
with a striking  absence of  polymorphonuclear leukocytes (4-6).  Immunofluores- 
cent  studies  have shown abundant amounts of  immunoglobulin and  complement 
in  synovial  tissue  (7,  8),  and synovial  fluids  contain  aggregates ofimmunoglobu- 
lin, rheumatoid factor-gamma globulin complexes, and nuclear antigen-anti- 
body complexes (9).  The etiology  of  RA has been considered  by many investiga- 
tors to be due  to the presence  of some  specific and persistent antigenic 
stimulation.  Much work has been directed  towards searching for  serum antibod- 
ies  to  bacteria  or  viruses  in the hope that  there might be clues  pointing  towards 
a specific  microbial agent. The results  have been conflicting  and generally 
inconclusive (10,  11). 
Recently, we demonstrated that the sera  of patients  with RA contained an 
antibody  which  reacted with a  cell-associated antigen  present  in human 
lymphocyte cell  lines.  This was demonstrated initially  by precipitin  lines  in 
immunodiffusion between rheumatoid sera  and soluble  extracts  of  tissue  culture 
cells, and the antibody in rheumatoid sera  was referred  to as RA precipitin 
(RAP) (12,  13).  Subsequently, the antigen was demonstrated by immunofluores- 
cence (14)  and it has now been shown to be distributed  predominantly in the 
nucleus of  tissue  culture  B-lymphocyte cell  lines.  Our hypothesis was that  this 
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antibody could be directed against a neoantigen in transformed lymphocytes. In 
this study, we present evidence to show that the nuclear antigen reactive with 
antibody  in  the  sera  of patients  with  RA  could be  induced  in  lymphocytes 
transformed by  Epstein-Barr  (EB) virus.  The  nuclear antigen  appears to be 
different from the Epstein-Barr nuclear antigen (EBNA). 
Materials and Methods 
Transformation  of  Human Peripheral Blood Lymphocytes with EB Virus.  200 ml of blood from 
each  of three  normal  individuals  was  collected  in  heparin,  and  the  leukocytes  separated  by 
dextran sedimentation. 30 ml of leukocyte-rich plasma was added to 10 ml of leukocyte separation 
medium  (Bionetics Laboratory  Products,  Kensington,  Md.),  centrifuged at 2,000  rpm at room 
temperature  for  10  min,  and  the  sedimented  leukocytes  washed with  RPMI  1640  (Associated 
Biomedic Systems, Inc., Buffalo, N.Y.). After centrifuging at 1,500 rpm for 10 rain, the procedure 
was repeated  a  second time.  The  method usually yielded 40  ml containing 1  x  106-1.5  ×  10  e 
leukocytes/ml. 
B-lymphocyte  line  (B95-8),  (supplied  by  Dr.  Berge  Hampar,  National  Cancer  Institute) 
producing Epstein-Barr virus  (EBV) was used as the source of virus for transformation. B95-8 
cells were cultured in RPMI  1640  with 10% fetal calf serum supplemented with glutamine and 
nonessential amino acids (Flow Laboratories, Inc., Rockville, Md.) and allowed to reach a  peak 
growth of 2.5  ×  106 cells/ml. The cells were spun down, resuspended at 2  ×  107 per ml in RPMI 
1640,  and sonicated at 4°C. The sonicate was then centrifuged and the supernate filtered through 
0.45 ~m Millipere filter (Millipore Corp., Bedford, Mass.). The virus pool was divided into small 
portions and stored at -70°C to be used as needed. 
20 ml of leukocyte suspension containing 2  ×  106 cells/ml was sedimented by centrifugation 
and resuspended in 1 ml of RPMI 1640 containing fetal calf serum (FCS). The cells were added to 
1  ml of undiluted virus from B95-8 cells,  and the suspension left at  37°C  for 30 rain to  allow 
adsorption of EBV. Infected cells were pipetted into two plastic 250-ml tissue culture flasks (Lux 
Scientific Corp., Newbury Park, Calif.), and 15 ml of fresh media containing FCS and supplements 
were added. Control cells which were not exposed to virus were handled separately and cultured 
at the same concentrations. Cultures were incubated as stationary suspension cultures at 37°C in 
a humidified atmosphere containing 5% COs. The cell cultures were frequently examined for cell 
morphology and given fresh media every 7 days. All three preparations of cells infected with EB 
virus were noted to undergo changes in cell culture characteristic of virus-induced transformation. 
By day 7, some large lymphocytes were forming clusters on the bottom of the flask.  By day 14, 
these clusters of lymphocytes were greatly enlarged, and in addition, clumps of cells were present 
in suspension in the culture medium.  From day 20 to 23, the number of large lymphocytes in 
suspension had  increased  significantly and the cells could be transferred for subculture on a 
rotary shaker. In contrast, two uninfected control cell lines showed decreasing numbers of cells on 
days  20-23  and  in  subsequent  weeks,  could  not  be  sustained  in  culture.  Cell  cultures  were 
harvested at various times and prepared for immunofluorescent studies by cytocentrifugation on 
to glass  slides. 
Extraction of  Soluble Antigen from Cells.  Suspensions of cells  (between 500 and 1,000  ml) 
from  each  cell  line  at  i × 10  ~  per ml  were  centrifuged  and  extracted  by  the  same method  described 
previously  for  WiLs  cells  (15).  Briefly,  this  consisted  of  recovering  cells  by  low  speed  centrifugation 
and  sonication  of  isolated  cells  in  a solution  of  0.25  M sucrose  and  0.04  M calcium  chloride  buffered 
at pH 6.2 with 0.01  M  phosphate. After centrifugation  at 105,000  g for  30 rain,  the supernate of 
sonicated  cells  was used as  the cell  extract  for  studies  in  immunodiffusion  in  agarose  against RA 
sera. 
Immunological Studies.  Two immunological assay systems  were used  for  detection  of  antigen 
which reacted  with serum antibody in RA sera (14).  Three prototype  sera  from patients  with RA 
had been previously characterized  and were used throughout these studies.  These sera reacted 
with  soluble  antigens in  extracts  of  WiL2  lymphocytes  by  immunodiffusion  to  give  precipitin  lines 
which were immunologically different  from precipitin  lines  caused by antibodies to nuclear 
antigens such  as  DNA, nucleoprotein,  Sin,  and  ribonucleoprotein  previously  described  (16).  It  was 
also  previously demonstrated that the precipitin  reaction  was not caused by rheumatoid factor 
(14).  In immunodiffusion studies  reported here, extracts  from EBV-transformed cell  lines  were 1020  LYMPHOCYTE8  TRANSFORMED  BY  EPSTEIN-BARR  VIRUS 
placed in  wells  adjacent  to  wells  containing WiL~ extracts,  and  tested  against prototype  RA sera. 
Precipitin  lines  with  extracts  of  transformed  cells  showing complete  fusion  with WiL2 lines  were 
taken  to  demonstrate  immunological identity  of  antigens in ~he  transformed  cell  line  extracts. 
Immunofluorescence  was  the  second  assay system  used.  The  three  prototype  RA sera  were  used 
as the intermediate reagents in the indirect  immunofluorescent  test  with fluorescein-conjugated 
anti-human IgG as the fluorescent  marker. These three RA sera were negative for nuclear 
staining when tissue  sections  from organs (mouse or human kidney and liver)  were used as 
substrates but reacted with WiL2 cells  to give nuclear staining  of discrete  finely speckled 
character.  The specificity  of  the reaction  had been  previously  demonstrated (14).  It  had also  been 
shown previously  that  nuclear staining  was  most  clearly  demonstrated  when cells  were fixed  with 
dry heat at 37°C for 30 rain.  Other fixatives  such as acetone and alcohol resulted in loss  of 
reactivity  of  this  nuclear antigen. The different  cell  lines  used in this  study were prepared for 
immunofluorescence by washing the harvested cells  in RPMI 1640 medium. Flat preparations  of 
cells  were made by  cytocentrifugation  on to  glass  slides  and  heated  at  37°C for  30 rain.  They were 
reacted  with  RA sera  for  30  rain  at  room temperature, washed, and  reacted  v~ith  fluorescent  anti- 
human IgG. RA sera  were usually used  at 1:4  dilution.  Several sera  from  patients  with Burkitt's 
lymphoma were made available  for  these  studies  through the courtesy  of  Dr. Guy de The, World 
Health Organization, Lyon, France. 
Differentiation  from  EBNA.  Reedman  and  Klein  (15)  have  described  an  EBNA  in  EBV- 
infected cells, and it was important to determine whether the nuclear antigen reacting with RA 
sera was similar or different. For determination of EBNA, cell lines were fixed in chilled acetone 
as described  (15).  Reference sera containing antibodies to  EBNA and sera negative for EBNA 
antibodies  (the latter also used as  a  source of complement) were supplied by  Dr.  B.  Hampar. 
Nuclear staining characteristic of EBNA was compared to that given by RA sera. 
Other Human and Simian Cell Lines Infected  with EBV and Related Herpes  Virus.  Several 
cell  lines of human and  simian origin  (cotton-topped  marmoset,  orangutan,  baboon,  and owl 
monkey) were obtained from the Frederick  Cancer Research Center,  Frederick,  Md.  (17).  The 
human cell lines were  umbilical cord lymphocytes,  transformed with EBV  (HCL-3/B95-8) and 
herpes  virus  papio  (HCL-3/KMPG-1).  Two  simian  cell  lines  CP-81  (18)  and  594-S  (19)  were 
lymphocyte lines established from animals who developed spontaneous lymphoid disease. Three 
other simian lymphocyte cell lines were from animals who developed lymphoid disease after in 
vivo inoculation with herpes virus (531-H, 1605-S,  and MLC-1 [20]) and another line (B95-8) was 
derived from in vitro transformation of isolated lymphocytes. With the exception of WiL2,  all the 
cell lines were under study in the laboratory of one of the authors  (H.  Rabin) and were being 
characterized with respect to the transforming activity and antigenicity of the herpes viruses 
present in simian cells (17).  The cells were prepared for immunofluorescent studies as described 
above and reacted with RA and serum with EBNA antibody to determine the presence or absence 
of RA-associated  nuclear  antigen  (RANA)  and  EBNA,  respectively.  Immunodiffusion studies 
were not performed with these cell lines. 
Results 
Immunofluorescent Studies on Cultured Human Lymphocyte Cell Lines.  The 
indirect  immunofluorescent  test  was  used  to  detect  the  presence  of antigen 
reactive  with  antibodies  in  RA  sera.  The  characteristic  pattern  of nuclear 
staining seen in WiL~  cells is illustrated  in Fig.  1 a.  In this cell line,  which is 
known to contain EB viral genome, the pattern of nuclear staining by using RA 
sera  and fluorescein-conjugated  anti-IgG  reagent  is  demonstrated  as  distinct 
fine speckled  nuclear staining.  This pattern of nuclear staining is unique and 
can  be readily  distinguished  from nuclear  staining  produced by antibodies  to 
DNA,  histones,  or nonhistone proteins such as Sm antigen and ribonucleopro- 
tein.  In  the  human  lymphocytes  infected  with  EBV,  no  staining  could  be 
detected  in  cells  taken  at  day  1  and  day  14  of culture.  By  day  20,  nuclear 
staining began to appear in the EBV-infected cells, showing up as a few distinct 
fine speckles of nuclear staining,  as illustrated in Fig.  1 b. This was present in ALSPAUGH,  JENSEN,  RABIN,  AND  TAN  1021 
Fro. i.  Indirect  immunofiuorescence to demonstrate the presence of nuclear antigen 
reactive  with antibody in RA sera.  Tissue culture  cells  were cytocentrifuged  on to glass 
slides,  reacted  with  RA serum  containing  antibody,  and  stained  with  fiuorescein-co~ugated 
anti-human  IgG.  (a) demonstrates the  discretely  distributed  finely speckled  nuclear 
staining  observed  on  WiL2  cells;  (b)  was  EBV-infected  peripheral  blood  leukocytes  at  day  20 
of  culture.  A few discretely  distributed  fine  nuclear speckles  were seen at  this  time and 
became more numerous after  the  cells  became more transformed  into  continuous lines;  (c) 
were  the  same EBV-infected  cells  (day  20)  reacted  with  normal  human serum;  and (d)  was 
a control  noninfected cell  culture at day 20, reacted with the same RA serum as in (b), 
showing absence  of  nuclear staining. 
approximately 10-20% of the infected cells. By day 49,  at least 70% of the cells 
were staining  in a  pattern similar to the staining  seen in WiL2 cells shown in 
Fig.  i a. Fig.  i c demonstrates that the same EBV-infected cells (at day 20) did 
not  react  with  normal  human  serum,  and  Fig.  ld  shows  that  the  control 
uninfected cell culture did not show nuclear staining with RA sera. Two other 
infected  cell  lines  showed  similar  induction  of this  nuclear  antigen  and  the 
corresponding control, uninfected cell cultures were completely negative. 
EBV-infected cells at day 49 were extracted as described, and the soluble ex- 
tract studied in immunodiffusion tests as illustrated in Fig. 2. A RA serum (RAP) 
containing precipitating  antibody to WiL2 extract also showed precipitin lines 
with  D.J.  and  K.H.  extracts  (two EBV-infected cell preparations),  and these 
lines fused in complete immunological identity with the WiL2 precipitin line. It 1022  LYMPHOCYTES  TRANSFORMED  BY  EPSTEIN-BARR  VIRUS 
FIG.  2.  Immunodiffusion study between  RA serum  containing  precipitating  antibody 
(RAP) and cell culture  extracts.  D.J. and K.H. were human peripheral  blood leukocytes 
infected  with  EB  virus  and  cell cultures  harvested  at  day  49.  Soluble antigens  were 
extracted in the same manner as that used for the lymphocyte line WiL2. Precipitin lines 
developed between RAP, and the three cell culture extracts  and the precipitin lines fused 
completely with one another to show immunological identity. 
was further shown that when RAP serum was absorbed with  WiL2 extract to 
remove precipitating antibody,  the absorbed serum  was no longer reactive in 
immunodiffusion with D.J.  and K.H.  extracts. 
Studies on Human and Simian Lines Containing EBV and Related Herpes 
Viruses.  The above studies suggested that the nuclear antigen reactive with 
serum  antibody in RA sera could be induced in human lymphocytes by EBV. 
The availability of a  number of well-characterized human and simian lympho- 
cyte  cell  lines  provided  the  opportunity  to  determine  whether  the  nuclear ALSPAUGH,  JENSEN,  RABIN,  AND  TAN 
TABLE  I 
EBNA and RANA in Human  and Simian Cell Lines 
1023 
Cell  line 
WiL~ 
HCL-3/B95-8 
HCI.-3/KMPG-1 
531-H 
895-8 
1605-S 
~'P-81 
594-S 
MLC- 1 
Animal 
Hun28n ~een 
Human umbilicus 
Human umbilicus 
0wl monkey-in vitro  EBV-induced lym- 
phoreticular  hyperplasia 
Cotton-topl~d marmoset-in  vitro  EBV- 
transformed lymphocytos 
Cotton-topped marmoset-in  vivo EBV- 
induced lymphoma 
Orangutan with monomyelogenous leu- 
kemia 
Baboon with lymphoreticular  hyperpla- 
sia 
Cotton-topped marmoset-H,  saimiri  in- 
duced lymphoma 
Transforming virus 
EBV 
EBV 
Herpes  (H) pap/o 
EBV 
EBV 
EBV 
Herpes pongo 
Herpes papio 
Herpes saimiri 
Lymphocyte cell type 
B 
B 
B 
B 
B 
B 
Undifferentiated 
B 
T 
Immun~uo~Bcent 
staining  ~r 
EBNA  RANA 
÷%%  ÷++ 
÷%+  %÷ 
÷++  + 
+++  + 
++  + 
+ 
antigen  was  induced  only  by  EBV  or  was  also  inducible  by  related  herpes 
viruses  of  simian  origin.  It  can  be  noted  (Table  I)  that  the  human  cord 
lymphocyte line infected with EBV (HCL-3/B95-8)  was positive for EBNA and 
for  the  nuclear  antigen  reactive  with  RA  sera,  but  cord  cells  infected  with 
herpes virus papio were negative for both antigens. We observed that simian cell 
lines which had been transformed in vitro with EBV  (B95-8) or obtained from 
animals  inoculated  in  vivo  with  EBV  (531-H  and  1605-S)  also  contained  the 
nuclear  antigen  reactive  with  RA sera.  On the other hand,  simian  cell  lines 
carrying  herpes-like  viruses  such as herpesvirus  pongo  (CP-81,  of orangutan 
origin),  herpesvirus  papio  (594-S,  of baboon origin),  and  herpesvirus  saimiri 
(MLC-1,  of  squirrel  monkey  origin)  were  negative  for  the  nuclear  antigen 
reactive  with  RA  sera.  It  was  noted that  the  WiL2  cell  line  was  stronger  in 
immunofluorescence for the RA-associated nuclear antigen than other cell lines 
positive  for  this  antigen.  The  cell  line  MLC-1,  which  was  from  a  marmoset 
which developed lymphoma after inoculation with herpesvirus saimiri had been 
characterized  as a T lymphocyte and was negative for either EBNA-like  or the 
RA-associated  nuclear  antigen.  These  studies  showed  a  close  relationship 
between  RA-associated  nuclear  antigen  and EBV-infected  cells,  but lack of a 
relationship  with  cells  infected  with  herpes-related  viruses  of simian  origin. 
Although most cells containing  RA-associated  nuclear antigen  also contained 
EBNA, there was lack of complete concordance, as shown by presence of EBNA- 
like antigen in cell line CP-81 but absence of RA-associated nuclear antigen. 
Differentiation from EBNA.  A  serum containing  antibody to EBNA  (from 
Dr.  B.  Hampar)  and  negative  for precipitating  antibody to  WiL2  extract  was 
compared  with  an RA serum negative  for antibody to EBNA but positive for 
precipitating antibody to WiL2.  WiL2 cells which have both EBNA and the RA- 
associated  nuclear antigen  were  used as substrate in indirect  immunofluores- 
cence.  Staining  for RA  nuclear  antigen  by RA serum was best  demonstrated 
with anti-IgG reagent and was not amplified with anti-C3. In contrast, staining 
for EBNA by anti-EBNA  serum was not demonstrable  with anti-IgG reagent 
but  was  strongly  positive  with  anti-C3,  as  described  by  Reedman  and  Klein 1024  LYMPHOCYTES  TRANSFORMED  BY  EPSTEIN-BARR  VIRUS 
TABLE  II 
Lack of Relationship between Antibodies to RANA and EBNA 
Sera 
Immunofluorescent  staining  for 
RANA  EBNA 
Precipitating 
antibody  to 
RANA 
RA 
VM  +  (32)  +  (256)  +  (16) 
VI  +  (16)  -  +  (4) 
TF  +  (16)  +  (512)  +  (4) 
Burkitt  lymphoma 
1440  -  +  (5,120)*  - 
1020  -  +  (2,560)  - 
1023  -  +  (80)  - 
1053  -  +  (1,280)  - 
1003  -  -  - 
Normal  sera 
CP  -  +  (128)  - 
MC  -  +  (256)  - 
BB  -  -  - 
JV  -  +  (256)  - 
*  Antibody  to EBNA  in Burkitt  lymphoma  sera were performed  through 
the  courtesy  of Dr.  G.  de The.  EBNA  antibody  studies  for the  other 
sera  were  performed  on WiL2 cells as were  all studies  for antibody  to 
RANA.  Numbers  in  parenthesis  represent  the  reciprocal  of  the 
highest  dilution  of sera  positive  for staining  or precipitation. 
(15).  In addition,  the patterns of nuclear staining were completely different in 
that  EBNA  staining  was  dense  and  clumpy  involving  the  entire  nucleus, 
whereas, RA nuclear antigen staining consisted of discrete, individual speckles 
as illustrated in Fig.  1. 
Further studies which differentiated the RANA from EBNA are presented in 
Table II. The three prototype RA sera used in these studies were all positive for 
antibody to RA nuclear antigen  by immunofluorescence and immunediffusion 
but  only  two  of the  three  had  antibody  to  EBNA.  The  lack  of relationship 
between the two nuclear  antigens  was also demonstrated  by sera of patients 
with  Burkitt's  lymphoma  and  certain  normal  sera.  In  many  instances,  high 
titers of antibodies to EBNA were not associated with any detectable antibodies 
to RANA, either by immunofluorescence or immunodiffusion. 
Discussion 
In an earlier study (14), it was demonstrated that the soluble nuclear antigen 
reactive with serum antibody in RA sera was present in human lymphocyte cell 
lines WiL2 and Raji but not present in a  variety of normal human and animal 
tissues. It was postulated that the nuclear antigen  might belong to a  class of 
nuclear  "derepressor" proteins present  in  rapidly proliferating  cells.  Another 
possibility was that the nuclear antigen might be a viral-induced protein since 
WiL~  and  Raji  cell  lines  are  B  lymphocytes  known  to  carry  EBV.  In  other 
studies not reported here, we have determined that RA-reactive nuclear antigen 
is not present in other rapidly proliferating tissue culture cell lines,  including ALSPAUGH~  JENSEN,  RABIN,  AND  TAN  1025 
monkey kidney cells  (CV-1), human fibroblast  cells  (WI38), and  human T 
lymphocytes (1301 and Molt4). The present studies suggest that it might be an 
EBV-associated  antigen.  This  is  supported  by  the  demonstration that  the 
nuclear antigen began to appear in human lymphocytes in the early stages of 
transformation induced by EBV and increased in intensity and in percentage of 
positive cells as transformation progressed. The nuclear antigen was present in 
human and simian lymphocytes  transformed with EBV, but not in lymphocytes 
transformed with herpesviruses of simian origin. Human lymphocytes were not 
strictly necessary for the expression of this nuclear antigen, since it could be 
detected in simian lymphocytes transformed with EBV. 
Our studies suggest that the RANA is different from EBNA. The antigens 
showed different patterns of nuclear staining and different reactivity to anti- 
complement and  anti-IgG  fluorescein reagents.  Heat  fixation was  the  best 
method  of preserving  the  RA-associated  antigen  for  its  demonstration by 
immunofluorescence, a  situation different from EBNA which is best demon- 
strated by fixation in cold acetone. Furthermore, certain sera contained antibod- 
ies to EBNA, but no antibodies to RA-associated antigen.  RA antibodies are 
also precipitating antibodies whereas antibody to EBNA has not been demon- 
strated by precipitation reactions. Once induced, the RANA can be demonstrated 
to be present at all times in EBV-transformed cells and is therefore different 
from the EBV-induced transient nuclear antigen recently described (21). 
These studies do not tell us if there is an etiological relationship between 
EBV  infection and  RA.  If a  relationship is present,  specific  host  and other 
factors  must  play  important  roles  since  EBV  has  been  implicated in  such 
diverse diseases as Burkitt's lymphoma, nasopharyngeal carcinoma, and infec- 
tious mononucleosis. However, if a persistent infectious agent should be one of 
the factors causing RA, the role of EBV might merit further study. 
Summary 
Sera from approximately two-thirds of patients with rheumatoid arthritis 
contain an antibody which is reactive with a nuclear antigen present in human 
B-lymphocyte tissue culture cells. The immunological reaction can be demon- 
strated by precipitation and immunofluorescence. Evidence is presented that 
the reactive nuclear antigen is associated with Epstein-Barr (EB) virus-trans- 
formed lymphocytes. Normal  human  peripheral  blood  lymphocytes did  not 
contain the nuclear antigen reactive with rheumatoid arthritis sera, but after 
infection with EB virus, they showed increasing amounts of reactive nuclear 
antigen as the cells were transformed into continuous lines. Several established 
human and simian lymphocyte  cell lines known to carry EB viral genomes were 
shown to contain rheumatoid arthritis-associated nuclear antigen. Evidence is 
presented  which  suggests  that  the  rheumatoid arthritis-associated  nuclear 
antigen is different from the previously described EB nuclear antigen. 
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